- ►annals.org [PDF] ME Josephson, DJ Callans, AE Buxton - Annals of internal medicine, 2000 - Am Coll Physicians Sudden cardiac death, which accounts for approximately 350 000 deaths each year,
is a major health care problem. Antiarrhythmic drugs have not been reliable in
preventing sudden cardiac death. Although ß-blockers, ... Cited by 23 - Related articles - BL Direct - All 4 versions
[CITATION] The Role of the Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac …
S Saba, WL Atiga, W Barrington, LI Ganz, … - Journal of Heart and Lung Transplantation, 2003 - Elsevier We identified 194 consecutive patients (age 51 ± 12 years) with New York Heart
Association Class 3 or 4 HF (ejection fraction 22 ± 9%) listed for cardiac
transplantation, 35 of whom underwent ICD implantation. Of the implanted ... Cited by 21 - Related articles - All 6 versions
L Alonso-Pulpón, L Almenar, MG Crespo, L … - Rev Esp Cardiol, 1999 - revespcardiol.org El trasplante cardíaco es la única terapéutica, junto con los inhibidores de
la enzima conversiva de la angiotensina, capaz de cambiar en forma sustancial la
evolución natural de los pacientes con insuficiencia cardíaca grave. Sin ... Cited by 22 - Related articles - Cached - All 6 versions
H Nägele, W Rödiger - Journal of Heart and Lung Transplantation, 1999 - Elsevier In 434 elective candidates for heart transplantation, submitted to our
institution in the years 1984–1997 (50% coronary artery disease, mean age 51.6
± 12 years, 86% males) medical therapy was adjusted according to the ... Cited by 27 - Related articles - All 6 versions
MGC Leiro, MJP Martín - Rev Esp Cardiol, 2004 - revespcardiol.org La insuficiencia cardíaca avanzada, definida también como el estadio D de la
insuficiencia cardíaca, se caracteriza por la presencia de una cardiopatía
estructural avanzada y síntomas de insuficiencia cardíaca en reposo a ... Cited by 31 - Related articles - Cached - All 6 versions
